Elevated pro-brain natriuretic peptide, troponin T and malnutrition inflammatory score in chronic hemodialysis patients with overt cardiovascular disease

Nephron - Clinical Practice

Volumn 117, Issue 3, 2011, Pages

  Trimarchi, Hernán ^a   Muryan, Alexis ^a   Campolo Girard, Vicente ^a   Dicugno, Mariana ^a   Barucca, Nanci ^a   Lombi, Fernando ^a   Young, Pablo ^a   Pomeranz, Vanesa ^a   Forrester, Mariano ^a   Alonso, Mirta ^a   Iriarte, Romina ^a   Díaz, Marisa Luisa ^a   Lindholm, Bengt ^b  

^a HOSPITAL BRITÁNICO DE BUENOS AIRES   (Argentina)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cardiovascular disease; End stage renal disease; Hemodialysis; Inflammation; Malnutrition; Malnutrition inflammatory score; Pro brain natriuretic peptide; Troponin T

Indexed keywords

ALBUMIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; HOMOCYSTEINE; TROPONIN T;

ADULT; AGE DISTRIBUTION; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD VESSEL GRAFT; BLOOD VESSEL PROSTHESIS; BODY MASS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE SEVERITY; HEART ARRHYTHMIA; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEMATOCRIT; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; MALNUTRITION INFLAMMATORY SCORE; NUTRITIONAL PARAMETERS; NUTRITIONAL STATUS; OBESITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT DURATION; ULTRAFILTRATION;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; KIDNEY FAILURE, CHRONIC; MALE; MALNUTRITION; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROSPECTIVE STUDIES; RENAL DIALYSIS; TROPONIN T;

EID: 77956084364     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320195     Document Type: Article

References (58)

1. Qureshi AR, Alevestrand A, Divino-Filho J, Gutierrez A, Heimbürger O, Lindholm B, Bergstrom J: Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol 2002;13: S28-S36.
2. Brunner FP, Selwood NH: Profile of patients on ART in Europe and death rates due to major causes of death groups. Kidney Int 2002;42(suppl 38): S4-S15.
3. USRDS: Excerpt from the United States Renal Data System 1999 Annual Report. Patient mortality and survival in ESRD. Am J Kidney Dis 1999;34(suppl 1): S74-S86.
4. Stenvinkel P, Carrero JJ, Axelsson J, Lindholm B, Heimbürger O, Massy Z: Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? Clin J Am Soc Nephrol 2008;3:505-521.
5. Valli A, Carrero JJ, Qureshi A, Garibotto G, Barany P, Axelsson J, Lindholm B, Stenvinkel P, Anderstam B, Suliman M: Elevated serum levels of S-adenosylhomocysteine, but not homocysteine, are associated with cardiovascular disease in stage 5 chronic kidney disease patients. Clin Chim Acta 2008;395:106-110.
6. Marckmann P: Nutritional status of patients on hemodialysis and peritoneal dialysis. Clin Nephrol 1988;29:75-78. (Pubitemid 18060063)
7. Enia G, Sicuso C, Alati G, Zocalli C: Subjective global assessment of nutrition in dialysis patients. Nephrol Dial Transplant 1993;8:1094-1098. (Pubitemid 23322624)
8. Gianciaruso B, Brunori G, Kopple JD, Traversa G, Panarello G, Enia G, et al: Crosssectional comparison of malnutrition in CAPD and hemodialysis patients. Am J Kidney Dis 1995;26:475-486.
9. Leavey SF, Strawderman RL, Jones CA, Prot FK, Held PJ: Simple nutritional indicators as independent predictors of mortality in hemodialysis patients. Am J Kidney Dis 1998;31:997-1006. (Pubitemid 28265197)
10. Qureshi AR, Alvestrand A, Danielsson A, Divino-Filho JC, Gutierrez A, Lindholm B, et al: Factors predicting malnutrition in hemodialysis patients: a cross-sectional study. Kidney Int 1998;53:773-782. (Pubitemid 28124295)
11. Lowrie EG, Lew NL: Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990;15:458-482. (Pubitemid 20174016)
12. Pollock CA, Ibels LS, Allen BJ, Ayass W, Caterson RJ, Waugh DA, et al: Total body nitrogen as a prognostic marker in maintenance dialysis. J Am Soc Nephrol 1995;6:82-88.
13. Acchiardo SR, Moore LW, Latour PA: Malnutrition as the main factor in morbidity and mortality of hemodialysis patients. Kidney Int 1993;S16:S199-S203.
14. Kopple JD, Zhu X, Lew NL, Lowrie EG: Body weight-for-height relationships predict mortality in maintenance hemodialysis patients. Kidney Int 1999;56:1136-1148. (Pubitemid 29411743)
15. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: Hypoalbuminemia, cardiac morbidity, and mortality in ESRD. J Am Soc Nephrol 1996;7:728-736. (Pubitemid 27466006)
16. Kaysen GA: Biological basis of hypoalbuminemia in ESRD. J Am Soc Nephrol 1998;9:2368-2376. (Pubitemid 28543818)
17. Rambod M, Bross R, Zitterkoph J, Benner D, Pithia RD, Colman S, et al: Association of malnutrition-inflammation score with quality of life and mortality in hemodialysis patients: a 5-year prospective cohort study. Am J Kidney Dis 2009;53:298-309.
18. Williams AJ, McArley A: Body composition, treatment time, and outcome in hemodialysis patients. J Ren Nutr 1999;9:157-162.
19. Rigaud D, Hassid J, Meulemans A, Poupard AT, Boulier A: A paradoxical increase in resisting energy expenditure in malnourished patients near death: the king penguin syndrome. Am J Clin Nutr 2000;72:355-360. (Pubitemid 30620638)
20. Moldavyr LL, Copeland EM 3rd: Proinflammatory cytokines, nutritional support, and the cachexia syndrome: interactions and therapeutic options. Cancer 1997;79:1828-1839. (Pubitemid 27176368)
21. Kaysen GA: Association between inflammation and malnutrition as risk factors of cardiovascular disease. Blood Purif 2006;24:51-55. (Pubitemid 41820822)
22. Stenvinkel P, Heimbürger O, Paultre F, Diczfalusy U, Wang T, Berglund L, Jogerstrand T: Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999;55:1899-1911. (Pubitemid 29197978)
23. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C: Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999;55:648-658. (Pubitemid 29082891)
24. Satyan S, Light R, Agarwal R: Relationships of N-terminal pro-BNP and cardiac troponin T to left ventricular mass and function and mortality in asymptomatic hemodialysis patients. Am J Kidney Dis 2007;50:1009-1019. (Pubitemid 350122814)
25. Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH: A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis 2001;38:1251-1263. (Pubitemid 34193111)
26. Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH: Comparing outcome predictability of markers of malnutrition-inflammation complex syndrome in haemodialysis patients. Nephrol Dial Transplant 2004;19:1507-1519. (Pubitemid 38796421)
27. Vanholder R, Massy Z, Argiles A, Spasovski G, Verbeke F, Lamiere N: Chronic kidney disease as a cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant 2005;20:1048-1056. (Pubitemid 40862092)
28. Hyre AD, Fox CS, Astor BC, Cohen AJ, Muntner P: The impact of reclassifying moderate CKD as a coronary heart disease risk equivalent on the number of US adults recommended lipid-lowering treatment. Am J Kidney Dis 2007;49:37-45. (Pubitemid 44932194)
29. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, et al: Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002;347:2010-2019. (Pubitemid 35461657)
30. Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, et al: Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 2002;13:1307-1320. (Pubitemid 34441412)
31. Cano NJ, Fouque D, Roth H, Aparicio M, Azar R, Canaud B, Chavenau P, et al: Intradialytic parenteral nutrition does not improve survival in malnourished hemodialysis patients: a 2-year multicenter, prospective, randomized study. J Am Soc Nephrol 2007;18:2583-2591. (Pubitemid 47378875)
32. Jamison RL, Hartigan P, Kaufman JS, Goldfarb DS, Warren SR, Guarino PD, Gaziano JM: Effect of homocysteine lowering on mortality and vascular disease in advanced CKD and ESRD. JAMA 2007;10:1163-1170.
33. Drueke TB, Locatelli F, Clyne N, Eckhardt KU, Macdougall IC, Tsakiris D, Burger HU, Scherag A: Normalization of hemoglobin levels in patients with CKD and anemia. N Engl J Med 2006;355:2071-2084. (Pubitemid 44749316)
34. Wanner C, Krane V, Marz W, Olschewski M, Mann JF, Ruf G, Ritz E: Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 2005;353:238-248. (Pubitemid 41058323)
35. Cheung AK, Sarnak MJ, Yan G, Dwyer JT, Heyka RJ, Rocco MV, Teehan BP, Levey AS: Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 2000;58:353-362. (Pubitemid 30429882)
36. Massy ZA, Taupin P, Jungers P, Landais P: Prediction model of coronary heart disease in patients with chronic kidney disease: role of plasma fibrinogen as a new prognostic variable. Prilozi 2005;26:63-77.
37. Sommerer C, Hecklele S, Schwenger V, Katus HA, Giannitsis E, Zeier M: Cardiac biomarkers are influenced by dialysis characteristics. Clin Nephrol 2007;68:392-400. (Pubitemid 350258768)
38. Braunwald E: Biomarkers in heart failure. N Engl J Med 2008;358:2148-2159.
39. Rosner MH: Measuring risk in ESRD: is Nterminal pro-BNP a useful marker? Kidney Int 2007;71:481-483.
40. Roberts MA, Hare DL, Ratnaike S: Cardiovascular biomarkers in CKD. Pathophysiology and implications for clinical management of cardiac disease. Am J Kidney Dis 2006;48:341-360. (Pubitemid 44262433)
41. Tang WH, Francis GS, Morrow DA: National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: clinical utilization of cardiac biomarker testing in heart failure. Circulation 2007;116: e99-e109. (Pubitemid 47450268)
42. Bruch C, Fischer C, Sindermann J, Stypmann J, Breithardt G, Gradaus R: Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic peptide in patients with heart failure with versus without chronic kidney disease. Am J Cardiol 2008;102:469-474.
43. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Wilson P, Vasan R: Impact of obesity on plasma natriuretic peptide levels. Circulation 2004;109:594-600. (Pubitemid 38198866)
44. Sarzani R, Dessi-Fulgheri P, Paci VM: Expression of natriuretic peptide receptors in human adipose and other tissues. J Endocrinol Invest 1996;19:581-585. (Pubitemid 26408098)
45. Dessi-Fulgheri P, Sarzani R, Tamburrini P, et al: Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients. J Hypertens 1997;15:1695-1699. (Pubitemid 28029666)
46. Morabito D, Vallotton MB, Lang U: Obesity is associated with impaired ventricular protein kinase C-MAP kinase signaling and altered ANP mRNA expression in the heart of adult Zucker rats. J Invest Med 2001;49:310-318. (Pubitemid 33009521)
47. Landsberg L: Obesity and hypertension: experimental data. J Hypertens Suppl 1992;10: S195-S201. (Pubitemid 23045187)
48. Sengenes C, Berlan M, De Glisezinski I: Natriuretic peptides: a new lipolytic pathway in human adipocytes. FASEB J 2000;14:1345-1351. (Pubitemid 30439743)
49. Engei S, Sharma AM: The rennin-angiotensin system and natriuretic peptides in obesityassociated hypertension. J Mol Med 2001;79:21-29. (Pubitemid 32250020)
50. Drechsler C, Krane V, Winkler K, Dekker FW, Wanner C: Changes in adiponectin and the risk of sudden death, stroke, myocardial infarction, and mortality in hemodialysis patients. Kidney Int 2009;76:567-575.
51. Tanaka T, Tsutamoto T, Sakai H, et al: Effect of atrial natriuretic peptide on adiponectin in patients with heart failure. Eur J Heart Fail 2008;10:360-366.
52. Iliou MC, Furemon C, Benoit MO, Tuppin P, Calonge VM, Moatti N, Buisson C, Jacquot C: Prognostic value of cardiac biomarkers in ESRD: Chronic Hemodialysis and New Cardiac Markers Evaluation (CHANCE) study. Am J Kidney Dis 2003;42:513-523. (Pubitemid 37048127)
53. Mallamaci F, Zocalli C, Parlongo S, et al: Troponin T is related to left ventricular mass and predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 2002;40:68-75. (Pubitemid 34701213)
54. Dierkes J, Domrose U, Westphal S: Cardiac troponin T predicts mortality in patients with ESRD. Circulation 2000;102:1964-1969.
55. Madsen LH, Ladefoged S, Corell P, et al: Nterminal pro-BNP predicts mortality in patients with ESRD in hemodialysis. Kidney Int 2007;71:548-554.
56. Nishikimi T, Futoo Y, Tamano K, et al: Plasma brain natriuretic peptide levels in chronic hemodialysis patients: influence of coronary artery disease. Am J Kidney Dis 2001;37:1201-1208. (Pubitemid 32525156)
57. DeFilippi C, Wasserman S, Rosanio S, et al: Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis. JAMA 2003;290:353-359. (Pubitemid 37430521)
58. Iliou MC, Fumeron C, Benoit MO, Tuppin P, Courvoisier CL, Calonge VM, Moatti N, Buisson C, Jacquot C; Chronic Haemodialysis and New Cardiac Markers Evaluation (CHANCE) Study: Factors associated with increased serum levels of cardiac troponins T and I in chronic haemodialysis patients. Chronic Haemodialysis And New Cardiac Markers Evaluation (CHANCE) study. Nephrol Dial Transplant 2001;16:1452-1458. (Pubitemid 32640603)